缺乏PCSK9促进了外围神经病变的发展
Ali K Jaafar1, Aurélie Paulo-Ramos1, Guillaume Rastoldo1
1Diabète athérothombose Thérapies Réunion Océan Indien, INSERM U1188, Université de la Réunion, Saint-Pierre, France.
JCI insight
|May 8, 2025
概括
在小鼠中,PCSK9缺乏会导致外围神经病变,影响疼痛感觉和神经结构. 这表明PCSK9对于维持周围神经健康和脂质平衡至关重要.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 遗传学 是一个遗传学.
背景情况:
- 蛋白转化酶亚素/素9型 (PCSK9) 调节低密度脂蛋白受体 (LDLR) 水平,影响血液中的LDL胆固醇.
- PCSK9表现出超出脂质新陈代谢的类效应,影响炎症,感染和癌症.
- 目前尚不清楚PCSK9在周围神经功能和脂质平衡中的作用.
研究的目的:
- 研究PCSK9缺乏对周围神经系统的影响.
- 阐明PCSK9影响神经结构和功能的机制.
主要方法:
- 使用了PCSK9基因被删除的小鼠模型 (PCSK9淘汰赛小鼠).
- 评估感官感知 (热和机械疼痛),神经组织学和外围神经中的分子标记.
- 分析了神经组织中的脂质含量,线粒体结构和甲蛋白样本.
主要成果:
- PCSK9缺乏导致了外围神经病变,由疼痛敏感性降低而证明.
- 组织学分析显示,PCSK9缺陷小鼠的 nociceptive Schwann 细胞减少,轴突胀和低髓化.
- 观察到CD36的升高,神经脂质含量增加,线粒体异常和甲胺积累.
结论:
- PCSK9在维持周围神经完整性和脂质平衡中发挥着重要作用.
- PCSK9缺乏导致带有明显结构和代谢变化的外围神经病变.
- 这些发现突显了PCSK9在神经系统中的新功能.
相关概念视频
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
189
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
189
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Peripheral Artery Disease I: Introduction
659
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
659
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
764
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59


